SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026149
Filing Date
2021-11-10
Accepted
2021-11-10 16:10:56
Documents
44
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20210930_10q.htm   iXBRL 10-Q 710766
2 EXHIBIT 31.1 ex_303744.htm EX-31.1 12163
3 EXHIBIT 31.2 ex_303745.htm EX-31.2 12059
4 EXHIBIT 32.1 ex_303746.htm EX-32.1 4836
5 EXHIBIT 32.2 ex_303755.htm EX-32.2 6008
  Complete submission text file 0001437749-21-026149.txt   3097624

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pbla-20210930.xsd EX-101.SCH 28689
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbla-20210930_cal.xml EX-101.CAL 20568
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20210930_def.xml EX-101.DEF 192220
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20210930_lab.xml EX-101.LAB 181041
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20210930_pre.xml EX-101.PRE 208039
11 EXTRACTED XBRL INSTANCE DOCUMENT snbp20210930_10q_htm.xml XML 388691
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39468 | Film No.: 211396670
SIC: 2834 Pharmaceutical Preparations